Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- FLUO.ST
- Price
- 40.90
- Stock movement up
- +4.20 (11.44%)
- Company name
- Fluoguide AS
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Biotechnology
- Market cap
- 557.06M
- Ent value
- 540.23M
- Price/Sales
- 481.06
- Price/Book
- 17.65
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -10.89%
- 3 year return
- -12.38%
- 5 year return
- 25.90%
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
FLUO.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 481.06 |
| Price to Book | 17.65 |
| EV to Sales | 466.52 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 13.62M |
| EPS (TTM) | -2.39 |
| FCF per share (TTM) | -2.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.16M |
| Gross profit (TTM) | 1.16M |
| Operating income (TTM) | -35.54M |
| Net income (TTM) | -32.61M |
| EPS (TTM) | -2.39 |
| EPS (1y forward) | -3.60 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -3068.91% |
| Profit margin (TTM) | -2815.72% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 20.16M |
| Net receivables | 0.00 |
| Total current assets | 32.90M |
| Goodwill | 0.00 |
| Intangible assets | 378.00K |
| Property, plant and equipment | 1.35M |
| Total assets | 34.89M |
| Accounts payable | 1.69M |
| Short/Current long term debt | 223.00K |
| Total current liabilities | 2.87M |
| Total liabilities | 3.32M |
| Shareholder's equity | 31.57M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -32.78M |
| Capital expenditures (TTM) | 850.00K |
| Free cash flow (TTM) | -33.63M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -103.28% |
| Return on Assets | -93.46% |
| Return on Invested Capital | -102.56% |
| Cash Return on Invested Capital | -105.80% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 37.60 |
| Daily high | 40.90 |
| Daily low | 35.10 |
| Daily Volume | 9K |
| All-time high | 177.94 |
| 1y analyst estimate | 135.96 |
| Beta | 1.13 |
| EPS (TTM) | -2.39 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 28 May 2025 |
Downside potential
Loading...
Downside potential data
| FLUO.ST | S&P500 | |
| Current price drop from All-time high | -77.02% | -12.89% |
| Highest price drop | -81.45% | -56.47% |
| Date of highest drop | 7 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -48.06% | -11.07% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 1071 days | 1805 days |
COMPANY DETAILS
Marketcap
557.06M
Marketcap category
Small-cap
Description
FluoGuide A/S, a clinical stage biotechnology company, focused on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company also develops FG002, which is in preclinical stage that allows surgeons to differentiate cancer from normal tissue during surgery through a novel uPAR-targeted luminescent technology. It has an agreement with Linköping University Hospital for the development of FG001 that is in the Phase I/II clinical trial for surgical removal of brain cancer; collaboration with Copenhagen University Hospital; collaboration with Intuitive Surgical, Inc. for robotics surgery in head and neck cancer. FluoGuide A/S was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
Employees
7
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
COPENHAGEN, DENMARK / ACCESS Newswire / March 27, 2025 / FluoGuide A/S (STO:FLUO) ("FluoGuide" or the "Company" held its annual general meeting on 27 March 2025. To the shareholders of FluoGuide A/S. ...
March 27, 2025
KØBENHAVN, DK / ACCESS Newswire / March 12, 2025 / FluoGuide A/S (STO:FLUO) The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 ...
March 12, 2025
KØBENHAVN, DENMARK / ACCESS Newswire / February 27, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 27 February 2025 - FluoGuide A/S ("FluoGuide" or the "Company") hereby publishes its annual rep...
February 27, 2025
KØBENHAVN, DENMARK / ACCESS Newswire / February 27, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 27 February 2025 - Fluoguide A/S ("FluoGuide" or the "Company") today releases its results for ...
February 27, 2025
KØBENHAVN, DK / ACCESSWIRE / January 15, 2025 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery,...
January 15, 2025
KØBENHAVN, DK / ACCESSWIRE / November 27, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 27 November 2024 - Fluoguide A/S ("FluoGuide" or the "Company") today releases its results for the period...
November 27, 2024
KØBENHAVN, DK / ACCESSWIRE / October 07, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biothech company specializing in precision cancer surgery...
October 7, 2024
KØBENHAVN, DK / ACCESSWIRE / May 30, 2024 / FluoGuide A/S (STO:FLUO) Copenhagen, Denmark, 30 May 2024 - FluoGuide A/S ("FluoGuide" or the "Company") today releases its results for the period 1 January...
May 30, 2024
COPENHAGEN, DENMARK / ACCESSWIRE / May 27, 2024 /FluoGuide A/S (STO:FLUO) Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery...
May 27, 2024